(Q48017506)

English

Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet.

scientific article published in August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420611%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420611%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

Vanessa Souza-Mello

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420611%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Carlos A Mandarim-de-Lacerda

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420611%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Julio Cesar Fraulob

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420611%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Marcia Barbosa Aguila

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420611%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

0 references

publication date

1 August 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420611%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Clinical Science

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420611%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

123

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420611%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420611%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

259-270

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420611%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Endoplasmic reticulum stress involved in the course of lipogenesis in fatty acids-induced hepatic steatosis

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

SREBPs: physiology and pathophysiology of the SREBP family

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice.

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

REVIEW: Efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Effect of rosuvastatin on insulin sensitivity in an animal model of insulin resistance: evidence for statin-induced hepatic insulin sensitization

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

The many facets of PPARgamma: novel insights for the skeleton

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Therapeutic roles of peroxisome proliferator-activated receptor agonists

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Rosiglitazone: possible complications and treatment of non-alcoholic steatohepatitis (NASH).

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice.

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Pharmacogenetic analysis of rosiglitazone-induced hepatosteatosis in new mouse models of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Cardiac safety profile of rosiglitazone: a comprehensive meta-analysis of randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

European regulatory body recommends suspension of rosiglitazone

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet.

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Effects of diet and exercise on metabolic disturbances in high-fat diet-fed mice

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Nonalcoholic fatty liver disease as a component of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Statin modulates insulin signaling and insulin resistance in liver and muscle of rats fed a high-fat diet

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Role of resistin in obesity, insulin resistance and Type II diabetes

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Effects of fasting and refeeding on ob gene expression in white adipose tissue of lean and obese (oblob) mice

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Hepatic lipid metabolism and non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Diseases of liporegulation: new perspective on obesity and related disorders

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Brain adipocytokine action and metabolic regulation.

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Transgenic mice overexpressing nuclear SREBP-1c in pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic islets

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP.

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

SREBPs suppress IRS-2-mediated insulin signalling in the liver.

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Genetic control of de novo lipogenesis: role in diet-induced obesity

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats.

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Enhanced GLUT2 gene expression in an oleic acid-induced in vitro fatty liver model

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Glucose-stimulated upregulation of GLUT2 gene is mediated by sterol response element-binding protein-1c in the hepatocytes

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE*3-leiden mice

1 reference

https://api.crossref.org/works/10.1042%2FCS20110373

21 January 2018

Identifiers

10.1042/CS20110373

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420611%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22420611%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48017506&oldid=1538945315"